eli lilly and company tirzepatide gets nod to launch weight-loss drug in Hong Kong - Bloomberg News Zepbound From Eli Lilly and

Your schedule, your side effects, your goals

Dozens of low cost versions are pressuring pricing for obesity and diabetes drugs, prompting Novo Nordisk to lower prices on its own GLP-1 brands

This inconsistency indicates a need for improved training, increased staffing, or both

The subpopulations of myeloid cells defined by their immunosuppression capacity are generated because of aberrant myeloid cells recruitment in tumors

It just needs more thrust

Application of transcription factors and epigenetic therapies in autophagy-related diseases Chemical compounds targeting transcription factors or epigenetic regulators have been explored as potential treatments for autophagy-associated diseases, including various cancers, CVDs, neurodegenerative disorders, and metabolic conditions